Part 3 of this series for Global Biosimilars Week, penned by Dracey Poore, director of biosimilars at Cardinal Health, ...

It’s hard to watch the news or scroll through social media without encountering stories about weight loss drugs like ...

Critical wins that underpinned the significant milestone included the following: first, the FDA confirmed that the amended ...

Using analysis from an open-label, long-term treatment study of the RNS ® System, Rapport will present key new data on the correlation between the reduction in long episode (LE) frequency (abnormal ...

Many seriously ill people die waiting for the FDA to approve drugs that regulators in other advanced countries have already ...

Some pet owners want a recall of a new arthritis drug for cats after their animals died, some in horrific ways, just days ...

The FDA also approved a protocol amendment for the confirmatory CardiAMP ... The last patient enrolled into the open-label roll-in cohort was treated in late August 2024. We expect the primary ...

Brooke began taking OGSIVEO on December 30, 2023, just a month after it was approved by the FDA for adults with progressing ...

The open-label study, dubbed IGNYTE-ESO ... The new data drop follows the FDA approval of Adaptimmune’s afami-cel, known ...

Learn more about how an anesthetic traditionally used for surgical procedures may help depression and what to expect during ...

“We are pleased to have been granted orphan drug designation by the U.S. FDA for AT-02 in ATTR amyloidosis,” said Gregory Bell, M.D., Chief Medical Officer at Attralus. “Current approved therapies ...

The Food and Drug Administration certainly gives little margarine for error after recalling nearly 80,000 pounds of Costco ...